Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma | Synapse
June 13, 2019Open Access
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Key Points
Key points are not available for this paper at this time.
Abstract
ClinicalTrials.gov identifier: NCT02657889.
Perguntar à IA
Like
Bookmark
Share
View Full Paper
Perguntar à IA
Like
Bookmark
Share
View Full Paper
Cite This Study
Konstantinopoulos et al. (Thu,) studied this question.